Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

The life sciences business is characterized by demands in preclinical discovery and research. Revvity has been able to offer a more complete workflow to customers in this segment, building off the ...

While marketers know that an omnichannel approach can deliver a more seamless brand experience, many pharma companies are still in the early stages of implementing fully integrated omnichannel ...

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started and How it’s Going” memes are looking ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

Domino’s Pizza stock faces challenges with top line growth, consistently missing sales targets, despite strong profitability.

The MAP Group, a pan-European specialist pharmaceutical and biotechnology strategic consultancy focused on driving therapies through the complex medical, regulatory and market access landscape to ...

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to ...